Fingerprint
Dive into the research topics of 'Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma
Yoon T. Jeen, So Y. Yoon, Sang W. Shin, Byung S. Kim, Young J. Mok, Chong S. Kim, Jin H. Hyun, Jun S. Kim, Yeul H. Kim
Research output: Contribution to journal › Article › peer-review
32
Citations
(Scopus)